Zimmer Biomet CEO reiterates that patient safety is the company's first priority, and that remediation efforts are progressing "with the sense of urgency."
News & Features
Breast health continues to move the needle for Hologic in its 3Q18 earnings, but the company is still trying to find its footing in the aesthetics market.
The two technology groups will collaborate to expand SCHOTT’s hermetic packaging portfolio with an innovative new glass micro bonding technology that will create new possibilities for electronic implantable devices.
United Therapeutics and Medtronic have received FDA approval for the SynchroMed II to deliver medication to treat pulmonary arterial hypertension.
Reva has received CE mark for the Motiv bioresorbable scaffold to be used for the treatment of below-the-knee peripheral artery disease.
The Freestyle Libre brand has been a game changer and a significant driver in sales for Abbott’s diabetes unit.
Physicians from Taiwan unveil new glasses that would allow surgeons to visualize a 3-D model of a patient’s anatomy in real time.
The dispute between the two companies arose when Zoll’s subsidiary terminated a product development agreement claiming AutoMedx failed to perform.
Click Therapeutics is a specialist in digital therapeutics and has raised about $17 million in its latest financing.
Be sure to understand Japan’s latest revision to its reimbursement policies, as it could influence your next filing.
With more investments and potential device clearances on the way, the Bioelectronics market is beginning to take off.